Switch to:

Synta Pharmaceuticals Inc (SNTA)Ownership Data

Short Interest History (%)

This is the historical short interest of Synta Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
January 15, 201519.09
December 31, 201419.46
December 15, 201419.66
November 28, 201419.42
November 14, 201419.04
October 31, 201419.15
October 15, 201420.09
September 30, 201420.44
September 15, 201420.74
August 29, 201420.83
August 15, 201422.09
July 31, 201422.41
July 15, 201420.55
June 30, 201420.49
June 13, 201421.89
May 30, 201422.62
May 15, 201425.09
April 30, 201425.67
April 15, 201417.42
March 31, 201419.47
March 14, 201421.24
February 28, 201441.77
February 14, 201441.02
January 31, 201438.73
January 15, 201440.02
December 31, 201341.22
December 13, 201338.94
November 29, 201334.8
November 15, 201347.78
October 31, 201347.04
October 15, 201355.23
September 30, 201353.07
September 13, 201349.11
August 30, 201349.88
August 15, 201351.05
July 31, 201347.3
July 15, 201342.82
June 28, 201340.2
June 14, 201336.83
May 31, 201334.8
May 15, 201332.01
April 30, 201324.94
April 15, 201323.85
March 28, 201325.77
March 15, 201324.47
February 28, 201320.83
February 15, 201319.78
January 31, 201318.58
January 15, 201317.55
December 31, 201219.27
December 14, 201220.06
November 30, 201219.48
November 15, 201218.76
October 31, 201218.35
October 15, 201217.84
September 28, 201216.53
September 14, 201217.24
August 31, 201216.82
August 15, 201217.51
July 31, 201215.65
July 13, 201214.01
June 29, 201214.37
June 15, 201214.09
May 31, 201210.46
May 15, 20129.05
April 30, 20128.44
April 13, 20128.01
March 30, 20127.41
March 15, 20127.56
February 29, 201212.81
February 15, 201213.7
January 31, 201213.2
January 13, 201211.99
December 30, 201112.04
December 15, 201113.05
November 30, 201113.84
November 15, 201115.86
October 31, 201115.61
October 14, 201114.73
September 30, 201114.36
September 15, 201114.69
August 31, 201113.97
August 15, 201112.6
July 29, 201111.76
July 15, 201111.14
June 30, 201111.12
June 15, 201111.47
May 31, 201110.4
May 13, 201111.19
April 29, 201110.19
April 15, 20119.2
March 31, 20118.72
March 15, 20117.9
February 28, 20117.24
February 15, 20117.25
January 31, 20117.18
January 14, 20116.97
December 31, 20107.27
December 15, 20106.88
November 30, 20105.7
November 15, 20106.14
October 29, 20106.01
October 15, 20106.16
September 30, 20106.35
September 15, 20105.87
August 31, 20106.03
August 13, 20105.19
July 30, 20105.58
July 15, 20105.31
June 30, 20105.28
June 15, 20105.7
May 28, 20105.6
May 14, 20105.6
April 30, 20104.78
April 15, 20103.86
March 31, 20103.49
March 15, 20103.39
February 26, 20102.62
February 12, 20102.68
January 29, 20102.67
January 15, 20102.38
December 31, 20092.73
December 15, 20092.2
November 30, 20092
November 13, 20092.07
October 30, 20092.04
October 15, 20092.03
September 30, 20092.13
September 15, 20092.45
August 31, 20092.74
August 14, 20094.83
July 31, 20095.6
July 15, 20095.38
June 30, 20095.59
June 15, 20095.19
May 29, 20096.5
May 15, 20096
April 30, 20096.13
April 15, 20095.96
March 31, 20096.8
March 13, 20099.54
February 27, 200912.43
February 13, 200910.25
January 30, 20099.09
January 15, 20098.82
December 31, 20087.09
December 15, 20087.31
November 28, 20087.24
November 14, 20087.38
October 31, 20087.59
October 15, 20087.98
September 30, 20088.81
September 15, 20088.87
August 29, 20087.94
August 15, 20088.24
July 31, 20088.27
July 15, 20089.02
June 30, 20086.48
June 13, 20085.45
May 30, 20084.75
May 15, 20084.34
April 30, 20084.51
April 15, 20084.05
March 31, 20083.72
March 14, 20084.07
February 29, 20083.84
February 15, 20083.02
January 31, 20082.02
January 15, 20082.03
December 31, 20071.79
December 11, 20071.85
November 27, 20071.89
November 9, 20072.1
October 26, 20072.49
October 10, 20073.87
September 25, 20071.47
September 11, 20071.4
August 10, 20071.56
July 10, 20071.33
June 12, 20071.19
May 10, 20070.83
April 10, 20070.66
March 12, 20070.01
February 12, 20070.24

Institutional Ownership History (%)

This the Institutional Ownership History of Synta Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
December 31, 201470
November 30, 201470
October 31, 201471
September 30, 201471
August 31, 201471
July 31, 201473
June 30, 201477
May 31, 201476
April 30, 201476
March 31, 201469
February 28, 201471
January 31, 201471
December 31, 201369
November 30, 201367
October 31, 201388
September 30, 201388
August 31, 201387
July 31, 201387
June 30, 201351
May 31, 201350
April 30, 201350
March 31, 201348
February 28, 201353
January 31, 201354
December 31, 201249
November 30, 201248
October 31, 201245
September 30, 201245
August 31, 201245
July 31, 201245
June 30, 201244
May 31, 201242
April 30, 201242
March 31, 201232
February 29, 201231
January 31, 201237
December 31, 201138
November 30, 201138
October 31, 201138
September 30, 201137
August 31, 201140
July 31, 201137
June 30, 201129
May 31, 201126
April 30, 201130
March 31, 201131
February 28, 201135
January 31, 201133
December 31, 201032
November 30, 201033
October 31, 201015
September 30, 201015
August 31, 201015
July 31, 201017
June 30, 201018
May 31, 201021
April 30, 201013
March 31, 201013
February 28, 201013
January 31, 201013
December 31, 200913
November 30, 200913
October 31, 200914
September 30, 200914
August 31, 200914
July 31, 200919
June 30, 200919
May 31, 200919
April 30, 200914
March 31, 200914
February 28, 200914
January 31, 200918
December 31, 200819
November 30, 200819
October 31, 200820
September 30, 200819
August 31, 200819
July 31, 200819
June 30, 200820
May 31, 200820
April 30, 200820
March 31, 200817
February 29, 200817
January 31, 200817

Insider ownership (%)

This is the historical insider ownership of Synta Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
December 31, 20149
November 30, 20147
October 31, 20147
September 30, 20147
August 31, 20147
July 31, 20147
June 30, 20148
May 31, 20148
March 31, 201420
February 28, 201420
January 31, 201421
December 31, 201321
November 30, 201321
October 31, 201321
September 30, 201321
August 31, 201321
July 31, 201321
June 30, 201321
May 31, 201321
April 30, 201323
March 31, 201323
January 31, 201323
November 30, 201223
October 31, 201225
September 30, 201225
August 31, 201225
July 31, 201225
June 30, 201218
May 31, 201220
April 30, 201220
March 31, 201220
February 29, 201220
January 31, 201220
December 31, 201120
November 30, 201119
October 31, 201118
September 30, 201118
August 31, 201118
July 31, 201118
June 30, 201118
May 31, 201118
April 30, 201118
March 31, 201117
February 28, 201118
January 31, 201118
December 31, 201018
November 30, 201018
October 31, 201014
September 30, 201014
August 31, 201014
July 31, 201014
June 30, 201014
May 31, 201013
April 30, 201013
March 31, 201013
February 28, 201015
January 31, 201015
December 31, 200913
November 30, 200913
October 31, 200913
September 30, 200913
August 31, 200913
July 31, 200913
June 30, 200913
May 31, 200913
April 30, 200913
March 31, 200913
February 28, 200913
January 31, 200913
December 31, 200813
November 30, 200813
October 31, 200813
September 30, 200813
August 31, 200813
July 31, 200813
June 30, 200813
May 31, 200813
April 30, 200825
March 31, 200825
February 29, 200825
January 31, 200825
December 31, 200726
November 30, 200726
October 31, 200726
September 30, 200726
August 31, 200726
July 31, 200726
June 30, 200726
May 31, 200726
April 30, 200726
March 31, 200726
February 28, 200726

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Bruce KovnerDirector, 10% Owner3,060,8602.81%2014-09-30
Dr. Safi R. Bahcall,PhDPresident and CEO1,853,1351.7%2013-12-31
Robert N. WilsonDirector704,1180.65%2014-07-01
Dr. Lan Bo Chen,PhD10% Owner620,0350.57%2009-08-06
Keith R. GollustDirector351,7660.32%2014-07-01
Chen SchorN/A150,0000.14%2014-12-08
Dr. Sumant Ramachandra,M.D.,PhDN/A75,000less than 0.1%2013-03-11
Marc R. SchneebaumN/A75,000less than 0.1%2014-12-08
William S. ReardonDirector41,439less than 0.1%2014-07-01
Dr. James G. Barsoum,PhDN/A40,000less than 0.1%2007-02-05

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Caxton Corp30,194,8982014-09-3027.7393.5590,887,000
OB Telecom Electronics Co Ltd8,121,4672014-04-308.710.0034,191,376
CxSynta LLC7,761,7162014-09-307.130.0023,362,765
KOF, LLC5,460,0002014-04-305.850.0022,986,600
Fidelity Management and Research Company3,725,3032014-09-303.420.0011,213,000
Jennison Associates LLC3,673,8672014-09-303.370.0111,058,000
Fidelity® Select Biotechnology Portfolio3,254,0172014-11-302.990.1010,315,234
BlackRock Fund Advisors2,818,6562014-09-302.590.008,484,000
Prudential Jennison Health Sciences2,599,8732014-11-302.390.288,241,597
Vanguard Group, Inc.1,732,9362014-09-301.590.005,216,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK